https://www.qadvis.com/wp-content/uploads/2025/10/hero-aurevia-news-QAdvis-Overly-burdensome-Quality-Management-System-QMS.png
450
800
christina
https://www.qadvis.com/wp-content/uploads/2025/04/qadvis-logo-2025-aurevia-NEG-web.svg
christina2025-10-20 15:29:052025-12-16 18:05:57Could an overly burdensom QMS be the organizations own doing
https://www.qadvis.com/wp-content/uploads/2025/10/hero-aurevia-news-QAdvis-Overly-burdensome-Quality-Management-System-QMS.png
450
800
christina
https://www.qadvis.com/wp-content/uploads/2025/04/qadvis-logo-2025-aurevia-NEG-web.svg
christina2025-10-20 15:29:052025-12-16 18:05:57Could an overly burdensom QMS be the organizations own doing
https://www.qadvis.com/wp-content/uploads/2025/10/hero-aurevia-news-QAdvis-FDA-new-guidance-transforms-software-validation.png
450
800
christina
https://www.qadvis.com/wp-content/uploads/2025/04/qadvis-logo-2025-aurevia-NEG-web.svg
christina2025-10-08 08:49:072025-12-16 18:06:08FDA CSA computer software assurance guidance transforms software validation
https://www.qadvis.com/wp-content/uploads/2025/10/Aurevia-image-Anna-Karin-Alm-and-Ulrika-Hammarstrom.png
1200
1800
christina
https://www.qadvis.com/wp-content/uploads/2025/04/qadvis-logo-2025-aurevia-NEG-web.svg
christina2025-10-02 13:23:022025-12-16 18:06:31Strategic clarity is the new currency in life science
https://www.qadvis.com/wp-content/uploads/2025/09/hero-aurevia-news-QAdvis-3-QAdvis-hero-banner-FDA-transparency-Part-3.png
450
800
christina
https://www.qadvis.com/wp-content/uploads/2025/04/qadvis-logo-2025-aurevia-NEG-web.svg
christina2025-09-18 12:59:522025-12-16 18:06:43Strategic considerations for a successful 510k Submission 3
https://www.qadvis.com/wp-content/uploads/2025/09/hero-QAdvis-Navigating-the-potential-impact-of-radical-transparency.png
450
800
christina
https://www.qadvis.com/wp-content/uploads/2025/04/qadvis-logo-2025-aurevia-NEG-web.svg
christina2025-09-10 06:33:332025-12-16 18:06:56Navigate the potential impact of radical transparency
https://www.qadvis.com/wp-content/uploads/2025/09/hero-QAdvis-Aurevia-news-FDA-transparency-policy-part-1.png
450
800
christina
https://www.qadvis.com/wp-content/uploads/2025/04/qadvis-logo-2025-aurevia-NEG-web.svg
christina2025-09-01 07:38:232025-12-16 18:07:09Will the FDAs new transparency policy extend to medical devices
We are delighted and proud to announce that QAdvis Group has achieved ISO 13485:2016 certification. This is a major milestone … Read more here!
At the core of every design and development process are the user needs. Too often, however, the user needs are limited to … Read more here!
Please feel free to use the contact form below
QAdvis is now officially part of Aurevia. This change of name follows our company’s integration into Aurevia. The Aurevia brand was born in January, when Labquality, Artimed, Clinical Consulting, Kasve, and Prisma CRO merged under the same name. With QAdvis now proudly joining the team, we are further strengthening our expertise and services and together offering greater value to our joint customers. Scandinavian CRO is also joining Aurevia.
